UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MHC-I genotype and tumor mutational burden predict response to immunotherapy

Genome medicine, 2020-05, Vol.12 (1), p.45-45, Article 45

2020

Volltextzugriff (PDF)

CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia

Cancer cell, 2016-11, Vol.30 (5), p.792-805

2016

Volltextzugriff (PDF)

RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML

Cell stem cell, 2016-11, Vol.19 (5), p.599-612

2016

Volltextzugriff (PDF)

A Rare Case of Richter Transformation to Both Clonally Unrelated and Clonally Related Diffuse Large B-Cell Lymphoma in the Same Patient

Case reports in hematology, 2024, Vol.2024 (1), p.7913296

2024

Volltextzugriff (PDF)

Predicting Responses to Checkpoint Inhibitors in Lymphoma: Are We Up to the Standards of Solid Tumors?

Clinical Medicine Insights. Oncology, 2020, Vol.14, p.1179554920976366-1179554920976366

2020

Volltextzugriff (PDF)

Extracorporeal photopheresis for the treatment of chronic graft versus host disease

Hematology (Luxembourg), 2022-12, Vol.27 (1), p.785-794

2022

Volltextzugriff (PDF)

MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR

Experimental hematology & oncology, 2021-02, Vol.10 (1), p.1-12, Article 8

2021

Volltextzugriff (PDF)

Ipilimumab for Patients with Relapse after Allogeneic Transplantation

The New England journal of medicine, 2016-07, Vol.375 (2), p.143-153

2016

Volltextzugriff (PDF)

Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants

Transfusion (Philadelphia, Pa.), 2014-07, Vol.54 (7), p.1857-1863

2014

Volltextzugriff (PDF)

Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults

Expert opinion on biological therapy, 2021-07, Vol.21 (7), p.849-862

2021

Volltextzugriff (PDF)

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4199-4206

2013

Volltextzugriff (PDF)

Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia

Blood, 2022-01, Vol.139 (3), p.424-438

2022

Volltextzugriff (PDF)

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

Blood, 2009-02, Vol.113 (7), p.1581-1588

2009

Volltextzugriff (PDF)

Toxicity-evaluation designs for phase I/II cancer immunotherapy trials

Statistics in medicine, 2010-03, Vol.29 (7-8), p.712-720

2010

Volltextzugriff (PDF)

Improved accuracy of clinical HLA genotyping by next-generation DNA sequencing affects unrelated donor search results for hematopoietic stem cell transplantation

Human immunology, 2018-12, Vol.79 (12), p.848-854

2018

Volltextzugriff (PDF)

A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2018-05, Vol.18 (5), p.346-352.e5

2018

Volltextzugriff (PDF)

Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2020-07, Vol.20 (7), p.431-437.e2

2020

Volltextzugriff (PDF)

Targeting Gastrin-Releasing Peptide Receptors on Small Cell Lung Cancer Cells with a Bispecific Molecule that Activates Polyclonal T Lymphocytes

Clinical cancer research, 2006-04, Vol.12 (7), p.2224-2231

2006

Volltextzugriff (PDF)

What are the latest advancements in acute myeloid leukemia therapy?

Future oncology (London, England), 2017-04, Vol.13 (10), p.867-871

2017

Volltextzugriff (PDF)

Monoclonal antibodies in the treatment of hematologic malignancy

Best practice & research. Clinical haematology, 2010-09, Vol.23 (3), p.403-416

2010

Volltextzugriff (PDF)

In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden

Cytotherapy (Oxford, England), 2021-04, Vol.23 (4), p.320-328

2021

Volltextzugriff (PDF)

Abstract 3338: Pacritinib reduces human myeloid leukemia stem cell maintance in a defined niche

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3338-3338

2016

Volltextzugriff (PDF)

A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis

Oncology (Williston Park, N.Y.), 2017-02, Vol.31 (2), p.122-128

2017

Volltextzugriff (PDF)

Novel FNDC3B and MECOM fusion and WT1 L378fs 7 frameshift mutation in an acute myeloid leukaemia patient with cytomorphological and immunophenotypic features reminiscent of acute promyelocytic leukaemia

British journal of haematology, 2016-03, Vol.172 (6), p.987-990

2016

Volltextzugriff (PDF)

1 – 25 von 520

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(467)
Mit Volltextzugriff
(441)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

MHC-I genotype and tumor mutational burden predict response to immunotherapy

CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia

RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation

A Rare Case of Richter Transformation to Both Clonally Unrelated and Clonally Related Diffuse Large B-Cell Lymphoma in the Same Patient

Predicting Responses to Checkpoint Inhibitors in Lymphoma: Are We Up to the Standards of Solid Tumors?

Extracorporeal photopheresis for the treatment of chronic graft versus host disease

MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR

Ipilimumab for Patients with Relapse after Allogeneic Transplantation

Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants

Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

Toxicity-evaluation designs for phase I/II cancer immunotherapy trials

Improved accuracy of clinical HLA genotyping by next-generation DNA sequencing affects unrelated donor search results for hematopoietic stem cell transplantation

A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia

Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma

Targeting Gastrin-Releasing Peptide Receptors on Small Cell Lung Cancer Cells with a Bispecific Molecule that Activates Polyclonal T Lymphocytes

What are the latest advancements in acute myeloid leukemia therapy?

Monoclonal antibodies in the treatment of hematologic malignancy

In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden

Abstract 3338: Pacritinib reduces human myeloid leukemia stem cell maintance in a defined niche

A 60-Year-Old Man With Progressive Anemia While Receiving Checkpoint Blockade Therapy for Relapsed Myelofibrosis

Novel FNDC3B and MECOM fusion and WT1 L378fs 7 frameshift mutation in an acute myeloid leukaemia patient with cytomorphological and immunophenotypic features reminiscent of acute promyelocytic leukaemia

Suchergebnisse filtern